abstract |
The present invention relates to substituted indazole compounds that modulate the activity of protein kinases, and therefore are useful for treating diseases caused by a deregulated protein kinase activity, such as cancer. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods for treating diseases using these compounds or pharmaceutical compositions containing them. |